Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.

She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.

Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.

Dr. Cesar Rodriguez has spent the last seven years dedicated to advancing the field of multiple myeloma — which he discussed in this week’s episode of the “

Rodriguez highlighted advances with precision medicine in the multiple myeloma treatment landscapes, and common questions patients have for their physicians.

Moreover, he also highlighted his recent trek to Patagonia with Moving Mountains for Multiple Myeloma, an effort partnered by 

 and the Multiple Myeloma Research Foundation. Through the trek, Rodriguez was able to meet with patients and their caregivers about a disease he has spent his career dedicated to finding more treatments for.

Podcasts

Myeloma

CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Cesar Rodriguez about precision medicine, and his recent trek to Patagonia with Moving Mountains for Multiple Myeloma.

Understanding Precision Medicine in Multiple Myeloma

Latest News